A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation

Clinical Infectious Diseases

Volumn 45, Issue 10, 2007, Pages 1296-1304

  Castagnola, Elio ^a   Fontana, Vincenzo ^b   Caviglia, Ilaria ^a   Caruso, Silvia ^a   Faraci, Maura ^a   Fioredda, Francesca ^a   Garrè, Maria Luisa ^a   Moroni, Cristina ^a   Conte, Massimo ^a   Losurdo, Giuseppe ^a   Scuderi, Franca ^a   Bandettini, Roberto ^a   Tomà, Paolo ^a   Viscoli, Claudio ^c   Haupt, Riccardo ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

ACUTE LEUKEMIA; ARTICLE; BACTEREMIA; CONTROLLED STUDY; FEBRILE NEUTROPENIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MYCOSIS; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RISK FACTOR; CHILD; FEMALE; ITALY; MALE; NEOPLASM; NEUTROPENIA; PRESCHOOL CHILD; PROSPECTIVE STUDY; PYREXIA IDIOPATHICA; STEM CELL TRANSPLANTATION;

ANTINEOPLASTIC AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER OF UNKNOWN ORIGIN; HUMANS; ITALY; MALE; MYCOSES; NEOPLASMS; NEUTROPENIA; PROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION;

EID: 36048990145     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/522533     Document Type: Article

References (33)

1. Pui CH, Boyett JM, Hughes WT, et al. Human granulocyte colonystimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. N Engl J Med 1997; 336:1781-7.
2. Cullen M, Steven N, Billingham L, et al. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 2005; 353:988-98.
3. Castagnola E, Boni L, Giacchino M, et al. A multicenter, randomized, double blind placebo-controlled trial of amoxicillin/clavulanate for the prophylaxis of fever and infection in neutropenic children with cancer. Pediatr Infect Dis J 2003; 22:359-65.
4. Bucaneve G, Micozzi A, Menichetti F, et al. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 2005; 353:977-87.
5. De Pauw BE, Donnelly JP. Prophylaxis and aspergillosis - has the principle been proven? N Engl J Med 2007; 356:409-11.
6. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003; 36:1103-10.
7. Girmenia C, Lo Coco F, Breccia M, et al. Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimen. Leukemia 2003; 17:925-30.
8. Romano V, Castagnola E, Dallorso S, et al. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation. Bone Marrow Transplant 1999; 23:271-5.
9. Haupt R, Romanengo M, Fears T, Viscoli C, Castagnola E. Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution. Eur J Cancer 2001; 37:2413-9.
10. Lalami Y, Paesmans M, Muanza F, et al. Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysis. Ann Oncol 2006; 17:507-14.
11. Castagnola E, Conte M, Parodi S, Papio F, Caviglia I, Haupt R. Incidence of bacteremias and invasive mycoses in children with high risk neuroblastoma. Pediatr Blood Cancer 2007; 49:672-7.
12. Castagnola E, Caviglia I, Pistorio A, et al. Bloodstream infections and invasive mycoses in children undergoing acute leukaemia treatment: a 13-year experience at a single Italian institution. Eur J Cancer 2005; 41:1439-45.
13. Lehrnbecher T, Varwig D, Kaiser J, Reinhardt D, Klingebiel T, Creutzig U. Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia 2004; 18:72-7.
14. Werba BE, Hobbie W, Kazak AE, Ittenbach RF, Reilly AF, Meadows AT. Classifying the intensity of pediatric cancer treatment protocols: the intensity of treatment rating scale 2.0 (ITR-2). Pediatr Blood Cancer 2007; 48:673-7.
15. Viscoli C, Castagnola E. Prophylaxis and empirical therapy for infection in cancer patients. In: Mandell GL, Bennett JE, Doolin R, eds. Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone, 2005:3442-62.
16. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7-14.
17. Akova M, Paesmans M, Calandra T, Viscoli C. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group study of secondary infections in febrile, neutropenic patients with cancer. Clin Infect Dis 2005; 40:239-45.
18. Measures of variations. In: Armitage P, Berry G, eds. Statistical methods in medical research. Oxford: Blackwell Scientific Publications, 1987: 32-41.
19. Cameron AC, Trivedi PK. Regression analysis of count data. Cambridge, United Kingdom: Cambridge University Press, 1998.
20. Mullen CA, Nair J, Sandesh S, Chan KW. Fever and neutropenia in pediatric hematopoietic stem cell transplant patients. Bone Marrow Transplant 2000; 25:59-65.
21. Nucci M, Andrade F, Vigorito A, et al. Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation. Transpl Infect Dis 2003; 5:167-73.
22. Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M. A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 1997; 99:580-8.
23. Marchetti O, Calandra T. Infections in the neutropenic cancer patient. In: Cohen J, Powderly EG, eds. Infectious diseases. London: Mosby, 2004:1077-92.
24. Yadegarynia D TJ, Raad I, Rolston K. Current spectrum of bacterial infections in patients with cancer. Clin Infect Dis 2003; 37:1144-5.
25. Castagnola E, Cesaro S, Giacchino M, et al. Fungal infections in children with cancer: a prospective, multicenter surveillance study. Pediatr Infect Dis J 2006; 25:634-9.
26. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91:1068-75.
27. Viscoli C, Girmenia C, Marinus A, et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999; 28:1071-9.
28. Hughes WT, Armstrong D, Bodey GP, et al. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34:730-51.
29. De Pauw B, Verveij PE. Infections in patients with hematologic malignancies. In: Mandell GL, Bennett JE, Doolin R, eds. Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone, 2005:3432-41.
30. Sonis ST, Oster G, Fuchs H, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 2001; 19:2201-5.
31. Neth O, Hann I, Turner MW, Klein NJ. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001; 358:614-8.
32. Vekemans M, Robinson J, Georgala A, et al. Low mannose-binding lectin concentration is associated with severe infection in patients with hematological cancer who are undergoing chemotherapy. Clin Infect Dis 2007; 44:1593-601.
33. Gafter-Gvili A, Fraser A, Paul M, Leibovici L. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients. Ann Intern Med 2005; 142(Pt 1):979-95.